Tumor necrosis factor alpha and the heart--can heart diseases be treated by neutralizing cytokines?
Ylitalo, K.; Peuhkurinen, K.
Duodecim; Laaketieteellinen Aikakauskirja 117(3): 256-259
2001
ISSN/ISBN: 0012-7183 PMID: 12092393 Document Number: 529883
Document emailed within 1 workday
Related Documents
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653Kunkel, S.L.; Strieter, R.M.; Chensue, S.W.; Basha, M.; Standiford, T.; Ham, J.; Remick, D.G. 1990: Tumor necrosis factor-alpha, interleukin-8 and chemotactic cytokines Progress in Clinical and Biological Research 349: 433-444
Jennings, G.R.; Castresana, M.R.; Newman, W.H. 2004: Regulation of tumor necrosis factor-alpha production in the isolated rat heart stimulated by bacterial lipopolysaccharide or reactive oxygen American Surgeon 70(9): 797-800
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Boffa, G.Maria.; Zaninotto, M.; Bacchiega, E.; Nalli, C.; Forni, M.; Tiso, E.; Cacciavillani, L.; Razzolini, R.; Plebani, M. 2005: Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 6(2): 125-132
Tziakas, D.; Chalikias, G.; Parissis, J.T.; Hatzinikolaou, H.; Stakos, D.; Papadopoulou, E.; Kortsaris, A.; Hatseras, D. 2004: Prolonged activation of tumor necrosis factor (TNF)-alpha and its soluble receptors in chronic heart failure patients both in the compensated and decompensated state. Interplay between their levels and metalloproteinase-3 European Cytokine Network 15(3): 231-239
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Aicher, K.P.; Dupon, J.W.; White, D.L.; Aukerman, S.L.; Moseley, M.E.; Juster, R.; Rosenau, W.; Winkelhake, J.L.; Brasch, R.C. 1990: Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha Cancer Research 50(22): 7376-7381
Bendtzen, K.; Hansen, P.R.; Rieneck, K. 2004: Spironolactone inhibits production of proinflammatory cytokines, including tumor necrosis factor-alpha and interferon-gamma and has potential effect in the treatment of arthritis Ugeskrift for Laeger 166(37): 3203-3207
Larsen, C.; Zachariae, C.; Mukaida, N.; Anderson, A.; Yamada, M.; Oppenheim, J.; Matsushima, K. 1990: Proinflammatory cytokines interleukin 1 and tumor necrosis factor induce cytokines that are chemotactic for neutrophils, T cells and monocytes Progress in Clinical and Biological Research 349: 419-431
Zabel, P.; Schlaak, M. 1993: Tumor necrosis factor alpha in lung diseases Pneumologie 47(2): 49-52
Bebök, Z.; Szekeres, G.; Horváth, G.; Duda, E.; Németh, P. 1993: Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use Orvosi Hetilap 134(24): 1303-1307
Egido, J.; Gómez-Chiarri, M.; Ortíz, A.; Bustos, C.; Alonso, J.; Gómez-Guerrero, C.; Gómez-Garre, D.; López-Armada, M.J.; Plaza, J.; Gonzalez, E. 1993: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases Kidney International. Suppl 39: S59-S64
Girolomoni, G.; Pastore, S.; Albanesi, C.; Cavani, A. 2002: Targeting tumor necrosis factor-alpha as a potential therapy in inflammatory skin diseases Current Opinion in Investigational Drugs 3(11): 1590-1595
2000: New concept in chronic heart failure. Blocking the function of tumor necrosis factor MMW Fortschritte der Medizin 142(13): 51
Chollet-Martin, S.; Depoix, J.P.; Hvass, U.; Pansard, Y.; Vissuzaine, C.; Gougerot-Pocidalo, M.A. 1990: Raised plasma levels of tumor necrosis factor in heart allograft rejection Transplantation Proceedings 22(1): 283-286
Packer, M. 1995: Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 92(6): 1379-1382
Daniel, L.W.; Civoli, F.; Rogers, M.A.; Smitherman, P.K.; Raju, P.A.; Roederer, M. 1995: ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha Cancer Research 55(21): 4844-4849
Takahashi, M.; Oshimi, K.; Mizoguchi, H. 1990: Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha Experimental Hematology 18(5): 395-399
Tanaka, N.; Kojima, K.; Muro, M.; Naomoto, Y.; Moreira, L.F.; Orita, K. 1995: Anti-proliferative and cytokinetic effects of tumor necrosis factor-alpha, interferon-alpha and 5-fluorouracil on a human tumor xenograft Anticancer Research 15(5b): 1949-1952